Dajia Weikang (301126.SZ) obtained oseltamivir phosphate granular drug registration certificate

Zhitongcaijing · 01/07 09:33

Zhitong Finance App News, Dajia Weikang (301126.SZ) announced that recently, the company's holding subsidiary Hunan Tianji Caotang Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for oseltamivir phosphate granules approved and issued by the State Drug Administration.

The indications for oseltamivir phosphate are: 1. It is used to treat influenza A and B in patients aged 2 weeks and above (oseltamivir phosphate can be effective in treating influenza A and B, but there is not much clinical application data for influenza B). Patients should use it within 48 hours of first onset of symptoms. 2. Used to prevent influenza A and B in people aged 1 year and above.